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On June 1, 2011, all baby bottles containing Bisphenol A (BPA) were removed from 
stores everywhere in the European Union (EU), following the very first international ban on the 
substance. This ban was a response to many differences in regulation of BPA among Member 
States. The European Commission press release for the occasion drew attention to these 
discrepancies: “In 2010, France and Denmark had taken national measures to restrict the use of 
Bisphenol A. France focussed on baby bottles only, while Denmark targeted also other food 
contact materials intended for children.” (1). 
 
If the European BPA decision intended to correct for differences in Member State 
policies about chemicals, this harmonization was short-lived. Five months later, in October, the 
French National Assembly banned the use of BPA for any type of food packaging, surpassing 
both the European ban on the use of BPA for baby bottles, and the Danish ban on food materials 
intended for children. That decision was justified by a report prepared, in the context of the 
REACH Regulation (2), by the French Agency for Food, Environmental and Occupational 
Health Safety (ANSES), whose recommendations challenged the conclusion of the European 
Food Safety Authority that the substance was safe for food contact applications. The ANSES 
report showed that the ingestion of BPA produces “‘recognized’ [harmful] effects in animals and 
other ‘suspected’ effects in humans (on reproduction, metabolism and cardiovascular diseases)” 
and recommended reducing population exposure to BPA (3). By following ANSES 
recommendations, French authorities appear to go against European-wide policies like REACH 
that are designed to harmonize chemical regulation among Member States so as to offer equal 
protection to all European citizens.  Instead of supporting harmonization, the French apparently 
opted for subsidiarity, insisting on the independence of French expertise (4). A closer look shows 
on the contrary that ANSES’ recommendations on BPA, as of other national agencies on 
different chemicals, feed the expertise that’s needed for European decisions to be made. The lens 
of chemical regulation enables STS researchers to analyze relations among nations, taking into 
account the complex linkages among the local, regional, and global levels where chemicals -and 
their risk assessments- circulate. 
 
Because REACH work routines are not in place yet, ANSES benefits from a good deal of 
discretionary power in the European procedures: the decision to study BPA further in spite of the 
European decision on baby bottles, the literature review, the selection of strategic data, the pitch 
and the rationale of the case are largely choices made by ANSES. In their website, ANSES 
confirms "the health effects of BPA for pregnant women in terms of potential risks to the unborn 
child" (5). The ANSES study, they add, “was carried out as part of a multidisciplinary, 
adversarial collective expert appraisal,” with a “working group specifically focusing on 
endocrine disrupters.” The specificity of the French agency’s expertise on BPA partly lies in its 
ability to put forward their strategic research orientation on endocrine disruptors: BPA had been 
for several years part of an ambitious program that included “mandates on risk assessment, 
scientific monitoring and reference activities for endocrine disruptors (6). This program is a 
major orientation of the agency, as endocrine disruptors are seen as political issue in France. 
Working on BPA, using the knowledge produced with this program and having the national 
restriction in baby bottles adopted at the European level suggest that an agency’s discretion can 
encourages European-wide restrictions. The novelty of the REACH provides a valuable window 
of opportunity to the French agency to implement practices of subsidiarity, of what the 
procedures should be, based on the national agenda and ANSES’ ongoing research programs 
 
The BPA case is an example of producing European regulatory science -by maintaining 
local control of expert judgment. EU institutions are often accused of lacking democratic 
accountability and legitimacy compared to Member States. With BPA, the practices of 
subsidiarity previously described show that the alleged democratic deficit is not systemic: 
national decisions can be used at the European level. This was this exact logic that led to the 
European ban of BPA in baby bottles to begin with. In a way, the discrepancies of expertise 
between Member States eventually lead to harmonization: European regulatory science, for 
instance in the REACH case, is in fact produced at the level of national health safety agencies 
that manage to create their own vision of doing expertise in the EU. 
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